Hillard CJ[au] - Search Results

Year	Number of Results
1982	1
1983	1
1984	1
1985	1
1986	1
1988	1
1989	1
1990	2
1991	1
1992	2
1993	2
1994	3
1995	5
1997	4
1998	4
1999	4
2000	7
2001	6
2002	2
2003	11
2004	13
2005	21
2006	6
2007	10
2008	15
2009	8
2010	15
2011	9
2012	12
2013	7
2014	9
2015	12
2016	11
2017	12
2018	12
2019	8
2020	16
2021	20
2022	17
2023	3

1

Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior.

Vickstrom CR, Liu X, Liu S, Hu MM, Mu L, Hu Y, Yu H, Love SL, Hillard CJ, Liu QS. Vickstrom CR, et al. Among authors: hillard cj. Mol Psychiatry. 2021 Jul;26(7):3178-3191. doi: 10.1038/s41380-020-00905-1. Epub 2020 Oct 22. Mol Psychiatry. 2021. PMID: 33093652 Free PMC article.

2

Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.

Ten-Blanco M, Flores Á, Pereda-Pérez I, Piscitelli F, Izquierdo-Luengo C, Cristino L, Romero J, Hillard CJ, Maldonado R, Di Marzo V, Berrendero F. Ten-Blanco M, et al. Among authors: hillard cj. Biomed Pharmacother. 2022 May;149:112925. doi: 10.1016/j.biopha.2022.112925. Epub 2022 Apr 9. Biomed Pharmacother. 2022. PMID: 35477218 Free article.

3

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.

Yu H, Liu X, Chen B, Vickstrom CR, Friedman V, Kelly TJ, Bai X, Zhao L, Hillard CJ, Liu QS. Yu H, et al. Among authors: hillard cj. Cells. 2021 Dec 16;10(12):3548. doi: 10.3390/cells10123548. Cells. 2021. PMID: 34944056 Free PMC article.

4

Editorial: Therapeutic potential of the cannabinoid CB2 receptor.

Smoum R, Grether U, Karsak M, Vernall AJ, Park F, Hillard CJ, Pacher P. Smoum R, et al. Among authors: hillard cj. Front Pharmacol. 2022 Oct 7;13:1039564. doi: 10.3389/fphar.2022.1039564. eCollection 2022. Front Pharmacol. 2022. PMID: 36278235 Free PMC article. No abstract available.

5

Dynamic Change of Endocannabinoid Signaling in the Medial Prefrontal Cortex Controls the Development of Depression After Neuropathic Pain.

Mecca CM, Chao D, Yu G, Feng Y, Segel I, Zhang Z, Rodriguez-Garcia DM, Pawela CP, Hillard CJ, Hogan QH, Pan B. Mecca CM, et al. Among authors: hillard cj. J Neurosci. 2021 Sep 1;41(35):7492-7508. doi: 10.1523/JNEUROSCI.3135-20.2021. Epub 2021 Jul 9. J Neurosci. 2021. PMID: 34244365 Free PMC article.

6

Meet Your Stress Management Professionals: The Endocannabinoids.

deRoon-Cassini TA, Stollenwerk TM, Beatka M, Hillard CJ. deRoon-Cassini TA, et al. Among authors: hillard cj. Trends Mol Med. 2020 Oct;26(10):953-968. doi: 10.1016/j.molmed.2020.07.002. Epub 2020 Aug 28. Trends Mol Med. 2020. PMID: 32868170 Free PMC article. Review.

7

Stress regulates endocannabinoid-CB1 receptor signaling.

Hillard CJ. Hillard CJ. Semin Immunol. 2014 Oct;26(5):380-8. doi: 10.1016/j.smim.2014.04.001. Epub 2014 May 29. Semin Immunol. 2014. PMID: 24882055 Free PMC article. Review.

8

Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.

Hillard CJ, Beatka M, Sarvaideo J. Hillard CJ, et al. Compr Physiol. 2016 Dec 6;7(1):1-15. doi: 10.1002/cphy.c160005. Compr Physiol. 2016. PMID: 28134998 Free PMC article. Review.

9

The Endocannabinoid Signaling System in the CNS: A Primer.

Hillard CJ. Hillard CJ. Int Rev Neurobiol. 2015;125:1-47. doi: 10.1016/bs.irn.2015.10.001. Epub 2015 Nov 6. Int Rev Neurobiol. 2015. PMID: 26638763 Free PMC article. Review.

10

Endocannabinoids and vascular function.

Hillard CJ. Hillard CJ. J Pharmacol Exp Ther. 2000 Jul;294(1):27-32. J Pharmacol Exp Ther. 2000. PMID: 10871291 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results